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Background: Subutex (buprenorphine) was approved by the Health Science Authority of Singapore for heroin detoxification in 2002. However, 
subutex abuse and its associated complications became arising medical problems. Since August 2006, subutex has been classified as a controlled 
drug and it can no longer be prescribed by general practitioners. The aim of this study is to study the changing epidemiology of infective endocarditis 
in an acute care hospital in Singapore, especially in relation to the abuse of subutex that is ironically meant for heroin detoxification.
Methods: Retrospective study on data of subjects diagnosed with infective endocarditis as the principal diagnosis for the past 7 years from 
January 2001 to December 2007.
Results: A total of 119 Infective Endocarditis (IE) cases (possible and definite) by Duke’s criteria were admitted during the study period. An analysis 
of the data revealed a rising yearly incidence of IE cases from Jan 2001 to Dec 2007. The peak incidence occurred in the year 2006 (27 cases) 
which coincided with the year that the Health Science Authority made subutex a controlled drug. The majority of the patients admitted for IE were 
Malays (57.98%) even though they made up less than a third of the Singaporean population. Males (73.1%) made up a greater proportion of IE 
admissions than females. The percentage of intravenous drug abusers had increased from 43.8% from January 2001 to June 2006 to 61.5% from 
July 2006 to December 2007. The commonest valve involved was mitral (47.5%) from January 2001 to June 2006 but had become the tricuspid 
valve instead (59.0%) subsequently. Thirteen patients had recurrent IE and all were intravenous drug abusers. The commonest organism was 
Staphylococcus aureus (58.0%). The mortality rate for IE admissions was 11.3% for the period January 2001 to June 2006 but had increased to 
20.5% subsequently.
Conclusions: The incidence of right-sided infective endocarditis has risen in tandem with the rising rate of intravenous drug abuse. By classifying 
subutex as a controlled drug, it is hoped that the incidence of IE and its associated morbidity and mortality will decrease.
